Pharmacotherapeutic perspectives on nutraceuticals in the treatment of MASLD and MASH

Ali H Eid¹, Maha Khachab², Firas Kobeissy³, Amirhossein Sahebkar^{4

5

6}

Affiliations

¹ Department of Basic Medical Sciences, College of Medicine, QU Health, Qatar University, Doha, Qatar.
² Department of Biomedical Sciences, Faculty of Medicine and Medical Sciences, University of Balamand, Beirut, Lebanon.
³ Department of Neurobiology, Morehouse School of Medicine, Atlanta, GA, USA.
⁴ Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
⁵ Centre for Research Impact & Outcome, Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab 140401, India.
⁶ Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.

Editorial

Ali H Eid et al. Ther Adv Chronic Dis. 2025.

. 2025 May 24:16:20406223251339388.

doi: 10.1177/20406223251339388. eCollection 2025.

Ali H Eid¹, Maha Khachab², Firas Kobeissy³, Amirhossein Sahebkar^{4

5

6}

¹ Department of Basic Medical Sciences, College of Medicine, QU Health, Qatar University, Doha, Qatar.
² Department of Biomedical Sciences, Faculty of Medicine and Medical Sciences, University of Balamand, Beirut, Lebanon.
³ Department of Neurobiology, Morehouse School of Medicine, Atlanta, GA, USA.
⁴ Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
⁵ Centre for Research Impact & Outcome, Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab 140401, India.
⁶ Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.

No abstract available

Keywords: NAFLD; Nutrition; Vitamin E; curcumin; nutraceutical; omega-3; phyotochemical; probiotic.

Conflict of interest statement

The authors declare that there is no conflict of interest.

1. Harrison SA, Bedossa P, Guy CD, et al. A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis. N Engl J Med 2024; 390: 497–509. - PubMed
1. Sahebkar A, Serban MC, Gluba-Brzózka A, et al. Lipid-modifying effects of nutraceuticals: an evidence-based approach. Nutrition 2016; 32: 1179–1192. - PubMed
1. Al-Menhali A, Al-Rumaihi A, Al-Mohammed H, et al. Thymus vulgaris (thyme) inhibits proliferation, adhesion, migration, and invasion of human colorectal cancer cells. J Med Food 2015; 18: 54–59. - PubMed
1. Fardoun M, Al-Shehabi T, El-Yazbi A, et al. Ziziphus nummularia inhibits inflammation-induced atherogenic phenotype of human aortic smooth muscle cells. Oxid Med Cell Longev 2017; 2017: 4134093. - PMC - PubMed
1. Mansour H, Slika H, Nasser SA, et al. Flavonoids, gut microbiota and cardiovascular disease: dynamics and interplay. Pharmacol Res 2024; 209: 107452. - PubMed